||“Comparison of Examination Practices for Medical-use Inventions Whose Intended Use Is Expressed by a Mechanism in Japan, the U.S., and Europe”
||Japan Patent Attorneys Association (JPAA)
||June 10, 2019, 16:30–17:30
||Benrishi-Kaikan Bldg., 2F conference room
||Yasumasa SASAKI (Mr.), patent attorney
||Examination practices for claims in which the active ingredient is expressed by its mechanism (i.e., reach through claims) and claims in which the intended use is expressed by its mechanism (i.e., intended use claims) were compared among Japan, the U.S., and Europe, and related differences and trends were explained. Some strategies based on the differences were also discussed.